Jim Cramer recommended on CNBC's Mad Money a long position in IDEXX Laboratories, Inc. IDXX. He thinks the stock is a secular growth story that could go on for years. He is a buyer of IDEXX Laboratories.
Cramer doesn't want to buy Express Scripts Holding Company ESRX because it's too risky.
Hanesbrands Inc. HBI should not be bought, thinks Cramer. He doesn't like Hanesbrands because it's involved with retail.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in